| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |